BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31860637)

  • 1. Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma.
    Hervás-Marín D; Higgins F; Sanmartín O; López-Guerrero JA; Bañó MC; Igual JC; Quilis I; Sandoval J
    PLoS One; 2019; 14(12):e0223341. PubMed ID: 31860637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
    Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
    Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation profiling identifies two subclasses of squamous cell carcinoma related to distinct cells of origin.
    Rodríguez-Paredes M; Bormann F; Raddatz G; Gutekunst J; Lucena-Porcel C; Köhler F; Wurzer E; Schmidt K; Gallinat S; Wenck H; Röwert-Huber J; Denisova E; Feuerbach L; Park J; Brors B; Herpel E; Nindl I; Hofmann TG; Winnefeld M; Lyko F
    Nat Commun; 2018 Feb; 9(1):577. PubMed ID: 29422656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling.
    Lambert SR; Mladkova N; Gulati A; Hamoudi R; Purdie K; Cerio R; Leigh I; Proby C; Harwood CA
    Br J Cancer; 2014 Jan; 110(2):520-9. PubMed ID: 24335922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes.
    Li L; Li F; Xia Y; Yang X; Lv Q; Fang F; Wang Q; Bu W; Wang Y; Zhang K; Wu Y; Shen J; Jiang M
    EBioMedicine; 2020 Jul; 57():102835. PubMed ID: 32574963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic age acceleration of cervical squamous cell carcinoma converged to human papillomavirus 16/18 expression, immunoactivation, and favourable prognosis.
    Lu X; Zhou Y; Meng J; Jiang L; Gao J; Fan X; Chen Y; Cheng Y; Wang Y; Zhang B; Yan H; Yan F
    Clin Epigenetics; 2020 Feb; 12(1):23. PubMed ID: 32041662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Genomic Landscape of Actinic Keratosis.
    Thomson J; Bewicke-Copley F; Anene CA; Gulati A; Nagano A; Purdie K; Inman GJ; Proby CM; Leigh IM; Harwood CA; Wang J
    J Invest Dermatol; 2021 Jul; 141(7):1664-1674.e7. PubMed ID: 33482222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.
    Dańczak-Pazdrowska A; Pazdrowski J; Polańska A; Basta B; Schneider A; Kowalczyk MJ; Golusiński P; Golusiński W; Adamski Z; Żaba R; Masternak MM
    Arch Dermatol Res; 2022 Apr; 314(3):257-266. PubMed ID: 33813600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mouse Papillomavirus Epigenetic Signature Is Characterised by DNA Hypermethylation after Lesion Regression.
    Tschirley AM; Stockwell PA; Rodger EJ; Eltherington O; Morison IM; Christensen N; Chatterjee A; Hibma M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
    Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinoma.
    Maly CJ; Cumsky HJL; Costello CM; Schmidt JE; Butterfield RJ; Zhang N; DiCaudo DJ; Nelson SA; Smith ML; Ochoa SA; Baum CL; Nagel TH; Pittelkow MR; Sekulic A; Mangold AR
    J Am Acad Dermatol; 2020 Apr; 82(4):846-853. PubMed ID: 31437542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.
    Korhonen N; Ylitalo L; Luukkaala T; Itkonen J; Häihälä H; Jernman J; Snellman E; Palve J
    Arch Dermatol Res; 2021 Dec; 313(10):879-884. PubMed ID: 32772261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer.
    Peters FS; Peeters AMA; Mandaviya PR; van Meurs JBJ; Hofland LJ; van de Wetering J; Betjes MGH; Baan CC; Boer K
    Clin Epigenetics; 2018; 10():81. PubMed ID: 29946375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
    Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.
    Campos MA; Macedo S; Fernandes M; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
    J Am Acad Dermatol; 2019 Mar; 80(3):660-669.e6. PubMed ID: 30165166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma.
    Wysong A; Newman JG; Covington KR; Kurley SJ; Ibrahim SF; Farberg AS; Bar A; Cleaver NJ; Somani AK; Panther D; Brodland DG; Zitelli J; Toyohara J; Maher IA; Xia Y; Bibee K; Griego R; Rigel DS; Meldi Plasseraud K; Estrada S; Sholl LM; Johnson C; Cook RW; Schmults CD; Arron ST
    J Am Acad Dermatol; 2021 Feb; 84(2):361-369. PubMed ID: 32344066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.
    Mizrahi A; Barzilai A; Gur-Wahnon D; Ben-Dov IZ; Glassberg S; Meningher T; Elharar E; Masalha M; Jacob-Hirsch J; Tabibian-Keissar H; Barshack I; Roszik J; Leibowitz-Amit R; Sidi Y; Avni D
    Oncogene; 2018 Jan; 37(2):218-230. PubMed ID: 28925390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
    Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
    J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.
    Que SKT; Zwald FO; Schmults CD
    J Am Acad Dermatol; 2018 Feb; 78(2):237-247. PubMed ID: 29332704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.